Evidence map›Paper›PMID 41867765›Full record

ArticlebioRxiv : the preprint server for biology2026

Preventing Disease Emergence Following Eradication: Application to Mpox.

Cora Hirst, Julia Deichmann, Ananya Saha, Ira Longini, Andreas Handel, Marc Lipsitch, Daniel Weissman, Rustom Antia

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cora HirstDepartment of Biology, Emory University, Atlanta, GA, USA.ORCID 0009-0005-3078-8729
Julia DeichmannDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.ORCID 0000-0003-1364-908X
Ananya SahaDepartment of Biology, Emory University, Atlanta, GA, USA.ORCID 0009-0002-8205-0716
Ira LonginiDepartment of Biostatistics, University of Florida, Gainesville, FL, USA.ORCID 0000-0002-2780-9382
Andreas HandelDepartment of Epidemiology and Biostatistics, University of Georgia, Athens, GA, USA.ORCID 0000-0002-4622-1146
Marc LipsitchDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.ORCID 0000-0003-1504-9213
Daniel WeissmanDepartment of Physics, Emory University, Atlanta, GA, USA.ORCID 0000-0002-7799-1573
Rustom AntiaDepartment of Biology, Emory University, Atlanta, GA, USA.ORCID 0000-0001-7991-614X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We use simple mathematical models to explore the factors that influence the evolutionary emergence of mpox to a pathogen capable of sustained human to human transmission that poses a global threat. Smallpox eradication followed by the discontinuation of immunization with vaccinia has led to a decline in the level of population immunity against related poxviruses such as mpox. This decline in immunity results in an increase in both the number of spillovers and the extent of human to human transmission. We find that increases in transmissibility of mpox between humans have a much greater effect on the probability of evolutionary emergence compared with increases in the number of zoonotic spillovers. We suggest that while mpox only needs to have a reproductive number slightly greater than one to become endemic, subsequent adaptation is likely to further increase its transmissibility in the human population. As a consequence a much higher level of vaccination (or other intervention) is needed to control the pathogen after its evolutionary emergence compared with what is needed to prevent it from emerging in the first place.

Identifiers

PMID41867765
PMCPMC13001426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.